↓ Skip to main content

Open-label, randomized, non-inferiority clinical trial of artesunate-amodiaquine versus artemether-lumefantrine fixed-dose combinations in children and adults with uncomplicated falciparum malaria in…

Overview of attention for article published in Malaria Journal, November 2014
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
74 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Open-label, randomized, non-inferiority clinical trial of artesunate-amodiaquine versus artemether-lumefantrine fixed-dose combinations in children and adults with uncomplicated falciparum malaria in Côte d'Ivoire
Published in
Malaria Journal, November 2014
DOI 10.1186/1475-2875-13-439
Pubmed ID
Authors

Offianan A Toure, Serge B Assi, Tiacoh L N’Guessan, Gbessi E Adji, Aristide B Ako, Marie J Brou, Marie F Ehouman, Laeticia A Gnamien, M’Lanhoro AA Coulibaly, Baba Coulibaly, Sylvain Beourou, Issiaka Bassinka, Adama Soumahoro, Florence Kadjo, Mea A Tano

Abstract

Emergence of artemisinin resistance has raised concerns that the most potent anti-malarial drug may be under threat. Artesunate-amodiaquine (AS-AQ) and artemether-lumefantrine (AL) are, respectively, the first- and second-line treatments for uncomplicated falciparum malaria in Cote d'Ivoire. Constant monitoring by National Malaria Control Programme (NMCP) of drug efficacy is an important tool in establishing rational anti-malarial drug policies in Cote d'Ivoire.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 74 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
Burkina Faso 1 1%
Unknown 72 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 14 19%
Student > Ph. D. Student 13 18%
Student > Master 10 14%
Student > Doctoral Student 5 7%
Student > Bachelor 4 5%
Other 11 15%
Unknown 17 23%
Readers by discipline Count As %
Medicine and Dentistry 18 24%
Agricultural and Biological Sciences 8 11%
Nursing and Health Professions 7 9%
Biochemistry, Genetics and Molecular Biology 6 8%
Social Sciences 6 8%
Other 10 14%
Unknown 19 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 November 2014.
All research outputs
#20,243,777
of 22,771,140 outputs
Outputs from Malaria Journal
#5,315
of 5,555 outputs
Outputs of similar age
#303,395
of 362,509 outputs
Outputs of similar age from Malaria Journal
#86
of 99 outputs
Altmetric has tracked 22,771,140 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 5,555 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.8. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 362,509 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 99 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.